Dr. Ranee Mehra shares guidance on recurrence, quality-of-life concerns and clinical trials for patients with head and neck cancers and caregivers. In an interview with CURE, Dr. Ranee Mehra, director ...
In an interview, Dr. Ranee Mehra, Director of Head and Neck Medical Oncology at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center and professor of medicine at the ...
Morning Overview on MSN
One drug shrank or erased tumors in 43 of 102 advanced head-and-neck cancer patients
A single drug shrank or eliminated tumors in 43 of 102 patients with advanced head-and-neck cancer that had stopped ...
A large clinical study recently published in The Lancet showed that patients treated with proton therapy for oropharyngeal cancers (cancers of the upper throat including the tonsils and back of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results